CONCEPT MOCK-UP · Pre-launch. Not a live store. Claims shown are drafts pending evidence. Nothing here is sent or sold.
Path to first unit

Three possible routes.

One decision is pending: where to launch first. Each route reuses the same formulation work.

Route A

South Africa first

SEDA Technology Transfer grant; local ISO 22716 contract manufacturer; 1,000-unit pilot over six months.

Route B

EU first (Austria)

EU independent chemist, FFG / AWS funding, EU Responsible Person, CPSR + CPNP. 8–12 months. Capital target €14–24k.

Route C

Dual launch

“Formulate once, comply everywhere.” 2,000 units split SA/EU. 10–14 months. Capital target €22–35k / R400–600k.

Shared milestones

  • Now

    Lock the formula version

    Decide v3.0 vs v3.1; reconcile every downstream document.

  • Next

    Company & grant paperwork

    Registration, tax, B-BBEE, banking, nine formal quotations.

  • Then

    Golden samples & Master Batch Record

    5 × 500 g lab prototypes; signed IP assignment.

  • Then

    Stability, preservative & safety testing

    Accredited-lab reports.

  • Then

    1,000-unit pilot batch

    ISO 22716 facility; CoA and release checklist.

  • Then

    Regulatory file & launch

    PIF / CPSR, barcodes, e-commerce.

Live progress is tracked on the internal dashboard.